Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety
Clinical trial NCT04125693 · COMPLETED
Trial details
- NCT number
- NCT04125693
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2021-02-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.